FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014336474> ?p ?o ?g. }

• W2014336474 endingPage "7204" @default.
• W2014336474 startingPage "7193" @default.
• W2014336474 abstract "N1-Aryl(heteroaryl)alkyl-N2-[3-(1H-imidazol-4-yl)propyl]guanidines are potent histamine H2-receptor (H2R) agonists, but their applicability is compromised by the lack of oral bioavailability and CNS penetration. To improve pharmacokinetics, we introduced carbonyl instead of methylene adjacent to the guanidine moiety, decreasing the basicity of the novel H2R agonists by 4-5 orders of magnitude. Some acylguanidines with one phenyl ring were even more potent than their diaryl analogues. As demonstrated by HPLC-MS, the acylguanidines (bioisosteres of the alkylguanidines) were absorbed from the gut of mice and detected in brain. In GTPase assays using recombinant receptors, acylguanidines were more potent at the guinea pig than at the human H2R. At the hH1R and hH3R, the compounds were weak to moderate antagonists or partial agonists. Moreover, potent partial hH4R agonists were identified. Receptor subtype selectivity depends on the imidazolylpropylguanidine moiety (privileged structure), opening an avenue to distinct pharmacological tools including potent H4R agonists." @default.
• W2014336474 created "2016-06-24" @default.
• W2014336474 creator A5007797524 @default.
• W2014336474 creator A5024194369 @default.
• W2014336474 creator A5033890880 @default.
• W2014336474 creator A5039010928 @default.
• W2014336474 creator A5039692094 @default.
• W2014336474 creator A5040439170 @default.
• W2014336474 creator A5043462774 @default.
• W2014336474 creator A5053965519 @default.
• W2014336474 creator A5055536770 @default.
• W2014336474 creator A5076233754 @default.
• W2014336474 creator A5076810446 @default.
• W2014336474 creator A5082356190 @default.
• W2014336474 creator A5088719485 @default.
• W2014336474 date "2008-10-25" @default.
• W2014336474 modified "2023-10-16" @default.
• W2014336474 title "Acylguanidines as Bioisosteres of Guanidines: <i>N</i>^G-Acylated Imidazolylpropylguanidines, a New Class of Histamine H₂ Receptor Agonists" @default.
• W2014336474 cites W1493538310 @default.
• W2014336474 cites W1825353903 @default.
• W2014336474 cites W1833104430 @default.
• W2014336474 cites W1930515007 @default.
• W2014336474 cites W1933763619 @default.
• W2014336474 cites W1967932389 @default.
• W2014336474 cites W1971176660 @default.
• W2014336474 cites W1976328813 @default.
• W2014336474 cites W1976862870 @default.
• W2014336474 cites W1978043003 @default.
• W2014336474 cites W1978820418 @default.
• W2014336474 cites W1994511427 @default.
• W2014336474 cites W1997825619 @default.
• W2014336474 cites W2001908693 @default.
• W2014336474 cites W2002885182 @default.
• W2014336474 cites W2010373231 @default.
• W2014336474 cites W2012783207 @default.
• W2014336474 cites W2029420571 @default.
• W2014336474 cites W2033731685 @default.
• W2014336474 cites W2041509453 @default.
• W2014336474 cites W2057971042 @default.
• W2014336474 cites W2058045382 @default.
• W2014336474 cites W2062165317 @default.
• W2014336474 cites W2064413753 @default.
• W2014336474 cites W2065448466 @default.
• W2014336474 cites W2068293422 @default.
• W2014336474 cites W2072211596 @default.
• W2014336474 cites W2073525592 @default.
• W2014336474 cites W2074631079 @default.
• W2014336474 cites W2074949244 @default.
• W2014336474 cites W2076978913 @default.
• W2014336474 cites W2077687762 @default.
• W2014336474 cites W2080231167 @default.
• W2014336474 cites W2083551870 @default.
• W2014336474 cites W2100532879 @default.
• W2014336474 cites W2103804378 @default.
• W2014336474 cites W2104286491 @default.
• W2014336474 cites W2104477830 @default.
• W2014336474 cites W2109592825 @default.
• W2014336474 cites W2114583428 @default.
• W2014336474 cites W2125991290 @default.
• W2014336474 cites W2144843461 @default.
• W2014336474 cites W2147993766 @default.
• W2014336474 cites W2149963584 @default.
• W2014336474 cites W2150155770 @default.
• W2014336474 cites W2150491175 @default.
• W2014336474 cites W2171756360 @default.
• W2014336474 cites W4252303924 @default.
• W2014336474 cites W62549861 @default.
• W2014336474 doi "https://doi.org/10.1021/jm800841w" @default.
• W2014336474 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18950149" @default.
• W2014336474 hasPublicationYear "2008" @default.
• W2014336474 type Work @default.
• W2014336474 sameAs 2014336474 @default.
• W2014336474 citedByCount "67" @default.
• W2014336474 countsByYear W20143364742012 @default.
• W2014336474 countsByYear W20143364742013 @default.
• W2014336474 countsByYear W20143364742014 @default.
• W2014336474 countsByYear W20143364742015 @default.
• W2014336474 countsByYear W20143364742016 @default.
• W2014336474 countsByYear W20143364742017 @default.
• W2014336474 countsByYear W20143364742018 @default.
• W2014336474 countsByYear W20143364742019 @default.
• W2014336474 countsByYear W20143364742021 @default.
• W2014336474 countsByYear W20143364742022 @default.
• W2014336474 crossrefType "journal-article" @default.
• W2014336474 hasAuthorship W2014336474A5007797524 @default.
• W2014336474 hasAuthorship W2014336474A5024194369 @default.
• W2014336474 hasAuthorship W2014336474A5033890880 @default.
• W2014336474 hasAuthorship W2014336474A5039010928 @default.
• W2014336474 hasAuthorship W2014336474A5039692094 @default.
• W2014336474 hasAuthorship W2014336474A5040439170 @default.
• W2014336474 hasAuthorship W2014336474A5043462774 @default.
• W2014336474 hasAuthorship W2014336474A5053965519 @default.
• W2014336474 hasAuthorship W2014336474A5055536770 @default.
• W2014336474 hasAuthorship W2014336474A5076233754 @default.
• W2014336474 hasAuthorship W2014336474A5076810446 @default.
• W2014336474 hasAuthorship W2014336474A5082356190 @default.
• W2014336474 hasAuthorship W2014336474A5088719485 @default.
• W2014336474 hasConcept C1122143 @default.

• next